CASP1 and colitis: Caspase-1 deficiency has been demonstrated to enhance tumor development in an AOM/DSS-induced colitis-associated colorectal cancer model through the regulation of colonic epithelial cell proliferation and apoptosis that is usually mediated by NLRC4 activity [91].